International Nonproprietary Names (INN) facilitate the identification of pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name.
WHO has a constitutional mandate to "develop, establish and promote international standards with respect to biological, pharmaceutical and similar products".
The World Health Organization collaborates closely with INN experts and national nomenclature committees to select a single name of worldwide acceptability for each active substance that is to be marketed as a pharmaceutical. To avoid confusion, which could jeopardize the safety of patients, trade-marks should neither be derived from INNs nor contain common stems used in INNs. The selection and publication of INNs falls under the responsibility of the EMP/RHT/TSN team of the INN Programme.
Dr R. Balocco Mattavelli World Health Organization |
Any change to the structure of a medicinal active substance will trigger a requirement for a new INN to be assigned. To highlight the close...
This document, first published on the website of the INN Programme in 2006, therefore presents an inventory of the policy decisions taken by the INN Expert...
-tug for “unmodified immunoglobulins”The suffix -tug is used for monospecific full-length immunoglobulins with unmodified constant...
During the 77th INN Consultation, 252 INN requests were discussed, including:• 217 new INN requests, of which 146 were for biological substances•...
During the 76th INN Consultation, a total of 271 INN requests was discussed, including:• 238 new INN requests, including 149 for biological substances•...
During the 75th INN Consultation, a total of 259 INN requests was discussed, including:• 212 new INN requests, including 121 for biological substances•...
Notice is hereby given that, in accordance with article 3 of the Procedure for the Selection ofRecommended International Nonproprietary Names for Pharmaceutical...
Notice is hereby given that, in accordance with article 3 of the Procedure for the Selection ofRecommended International Nonproprietary Names for Pharmaceutical...
Notice is hereby given that, in accordance with article 3 of the Procedure for the Selection ofRecommended International Nonproprietary Names for Pharmaceutical...
Notice is hereby given that, in accordance with article 3 of the Procedure for the Selection of Recommended International Nonproprietary Names for Pharmaceutical...
Notice is hereby given that, in accordance with article 3 of the Procedure for the Selection of Recommended International Nonproprietary Names for Pharmaceutical...
Notice is hereby given that, in accordance with article 3 of the Procedure for the Selection of Recommended International Nonproprietary Names for Pharmaceutical...